Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Central carbon metabolism in cancer	5/70	1.0300956143193924e-08	8.937402987400707e-07	123.12307692307692	-308.3116784019305	AKT1;MTOR;PIK3CA;PTEN;RET
KEGG_2021_Human	Glioma	5/75	1.4651480307214275e-08	8.937402987400707e-07	114.25714285714285	-291.91790397658275	AKT1;CDKN2A;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Pathways in cancer	7/531	5.145953593955757e-07	1.7911901198196118e-05	33.592875318066156	-117.25791336202394	AKT1;CDKN2A;MTOR;PIK3CA;PTEN;RET;VHL
KEGG_2021_Human	Cellular senescence	5/156	5.872754491211842e-07	1.7911901198196118e-05	52.43046357615894	-158.56563762209623	AKT1;CDKN2A;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Melanoma	4/72	1.1701896109043542e-06	2.0394733218618746e-05	78.43137254901961	-179.82105034024002	AKT1;CDKN2A;PIK3CA;PTEN
KEGG_2021_Human	Non-small cell lung cancer	4/72	1.1701896109043542e-06	2.0394733218618746e-05	78.43137254901961	-179.82105034024002	AKT1;CDKN2A;PIK3CA;RET
KEGG_2021_Human	Hepatocellular carcinoma	5/168	8.493017345096659e-07	2.0394733218618746e-05	48.49693251533742	-148.5218030993381	AKT1;CDKN2A;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Pancreatic cancer	4/76	1.4558243895816926e-06	2.2201321941120813e-05	74.03703703703704	-172.05130589538587	AKT1;CDKN2A;MTOR;PIK3CA
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	4/89	2.7491085630604124e-06	3.726569385481893e-05	62.61176470588235	-150.9687540546772	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Prostate cancer	4/97	3.882535399026648e-06	4.736693186812511e-05	57.168458781362006	-140.4227070470985	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	HIF-1 signaling pathway	4/109	6.189245110865825e-06	6.292399196046922e-05	50.55873015873016	-127.11709090748279	AKT1;MTOR;PIK3CA;VHL
KEGG_2021_Human	Insulin resistance	4/108	5.9656924897832925e-06	6.292399196046922e-05	51.05128205128205	-128.12895940589095	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Autophagy	4/137	1.5363738345825308e-05	0.0001441827752454375	39.774436090225564	-104.03256013781805	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	MicroRNAs in cancer	5/310	1.733013202148908e-05	0.0001510197219015477	25.452459016393444	-83.35482403333184	CDKN2A;DICER1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Breast cancer	4/147	2.0304341193526998e-05	0.00016514197504068626	36.946386946386944	-97.65028859286629	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	mTOR signaling pathway	4/154	2.4400135505395987e-05	0.0001860510332286444	35.19111111111111	-93.61108375071908	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Endometrial cancer	3/58	4.0678393529377954e-05	0.0002919272947402418	62.43896103896104	-110.94009813873689	AKT1;PIK3CA;PTEN
KEGG_2021_Human	Acute myeloid leukemia	3/67	6.278481738010982e-05	0.00042554154002074436	53.598214285714285	-98.46843432757142	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Renal cell carcinoma	3/69	6.857856994284154e-05	0.0004403466070014036	51.96103896103896	-96.07609532933417	AKT1;PIK3CA;VHL
KEGG_2021_Human	Diabetic cardiomyopathy	4/203	7.221114673256542e-05	0.0004404879950686491	26.36180904522613	-72.26295411298177	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Chronic myeloid leukemia	3/76	9.159620399517935e-05	0.0005321303279719943	46.93737769080235	-88.55605413655218	AKT1;CDKN2A;PIK3CA
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	4/219	9.708345438267137e-05	0.000538371883394814	24.350387596899225	-67.12577033726024	AKT1;CDKN2A;PIK3CA;PTEN
KEGG_2021_Human	Human cytomegalovirus infection	4/225	0.00010785574304042276	0.0005721043761274599	23.671191553544496	-65.36509727839072	AKT1;CDKN2A;MTOR;PIK3CA
KEGG_2021_Human	Colorectal cancer	3/86	0.0001324740846980751	0.0006464735333266065	41.230636833046475	-79.65388581050792	AKT1;MTOR;PIK3CA
KEGG_2021_Human	ErbB signaling pathway	3/85	0.00012793645194335274	0.0006464735333266065	41.73867595818815	-80.46318508481777	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Small cell lung cancer	3/92	0.00016192103282048912	0.0007597833078499875	38.42215088282504	-75.11644417571499	AKT1;PIK3CA;PTEN
KEGG_2021_Human	Choline metabolism in cancer	3/98	0.0001953427473376157	0.0008826598213033006	35.96842105263158	-71.05939608138371	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Longevity regulating pathway	3/102	0.00021994493140062025	0.0009583314868169882	34.497835497835496	-68.58379435140506	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Sphingolipid signaling pathway	3/119	0.0003468783323520502	0.0013890479388632682	29.379310344827587	-59.68521503911596	AKT1;PIK3CA;PTEN
KEGG_2021_Human	Thyroid hormone signaling pathway	3/121	0.00036434044298052937	0.0013890479388632682	28.87409200968523	-58.78131250266827	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Growth hormone synthesis, secretion and action	3/119	0.0003468783323520502	0.0013890479388632682	29.379310344827587	-59.68521503911596	AKT1;MTOR;PIK3CA
KEGG_2021_Human	AMPK signaling pathway	3/120	0.0003555398588827732	0.0013890479388632682	29.124542124542124	-59.230009444204136	AKT1;MTOR;PIK3CA
KEGG_2021_Human	FoxO signaling pathway	3/131	0.0004602084037564585	0.0017013765229784222	26.584821428571427	-54.62268457986884	AKT1;PIK3CA;PTEN
KEGG_2021_Human	Human papillomavirus infection	4/331	0.0004777466484480537	0.0017142673856077222	15.781855249745158	-43.81753827074924	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Insulin signaling pathway	3/137	0.0005248515914701949	0.0018294826902675366	25.375266524520256	-52.38188378130509	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Spinocerebellar ataxia	3/143	0.0005950854077497673	0.0020166783262631004	24.26938775510204	-50.30529409222555	AKT1;MTOR;PIK3CA
KEGG_2021_Human	PI3K-Akt signaling pathway	4/354	0.0006170414755932672	0.002034569189794016	14.700952380952382	-40.688114366493096	AKT1;MTOR;PIK3CA;PTEN
KEGG_2021_Human	Gastric cancer	3/149	0.0006711090600743852	0.002099366803309615	23.25440313111546	-48.37496566440217	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Phospholipase D signaling pathway	3/148	0.0006580280370873506	0.002099366803309615	23.417733990147784	-48.687210890592894	AKT1;MTOR;PIK3CA
KEGG_2021_Human	JAK-STAT signaling pathway	3/162	0.000856615716023289	0.0026126779338710316	21.318059299191376	-44.62403509135876	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Neutrophil extracellular trap formation	3/189	0.0013399484035926713	0.003987163542397705	18.161290322580644	-38.30003183551744	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Type II diabetes mellitus	2/46	0.0013867643520264008	0.004013360264302841	45.59090909090909	-53.767249912981214	MTOR;PIK3CA
KEGG_2021_Human	Carbohydrate digestion and absorption	2/47	0.001447441406797746	0.004013360264302841	44.57222222222222	-52.81565568615274	AKT1;PIK3CA
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	3/193	0.0014235649100074823	0.004013360264302841	17.769924812030077	-37.496518500419114	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Focal adhesion	3/201	0.0016005928499043844	0.004339385059740775	17.034632034632036	-35.97452728368245	AKT1;PIK3CA;PTEN
KEGG_2021_Human	Proteoglycans in cancer	3/205	0.0016941022902244062	0.004493053900160382	16.68882602545969	-35.25303962280841	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Human immunodeficiency virus 1 infection	3/212	0.0018659404176712966	0.004843504913955281	16.115516062884485	-34.04865723073064	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Regulation of lipolysis in adipocytes	2/55	0.0019779052882580696	0.0050271759409892605	37.806603773584904	-46.277866103498205	AKT1;PIK3CA
KEGG_2021_Human	VEGF signaling pathway	2/59	0.0022729027659621377	0.005659064029538384	35.1359649122807	-43.58275967856779	AKT1;PIK3CA
KEGG_2021_Human	Ras signaling pathway	3/232	0.0024164136009215383	0.0058960491862485535	14.670617592014972	-30.966105875434415	AKT1;NF1;PIK3CA
KEGG_2021_Human	GnRH secretion	2/64	0.0026692305210442593	0.006262425453219224	32.28225806451613	-40.62246695267589	AKT1;PIK3CA
KEGG_2021_Human	Chemical carcinogenesis	3/239	0.0026306580335614905	0.006262425453219224	14.2227602905569	-29.996427445990946	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Shigellosis	3/246	0.002856466854245349	0.006575263324866653	13.800705467372135	-29.076248648200146	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Fc epsilon RI signaling pathway	2/68	0.0030081604419031007	0.006796214331707006	30.310606060606062	-38.524679686703344	AKT1;PIK3CA
KEGG_2021_Human	Adipocytokine signaling pathway	2/69	0.0030959091544989293	0.006867289397252171	29.854477611940297	-38.032897794694755	AKT1;MTOR
KEGG_2021_Human	Prolactin signaling pathway	2/70	0.0031848593502604382	0.006938443584495955	29.41176470588235	-37.553176952571945	AKT1;PIK3CA
KEGG_2021_Human	p53 signaling pathway	2/73	0.0034588938624005605	0.007275604331256352	28.158450704225352	-36.181927711809635	CDKN2A;PTEN
KEGG_2021_Human	Inositol phosphate metabolism	2/73	0.0034588938624005605	0.007275604331256352	28.158450704225352	-36.181927711809635	PIK3CA;PTEN
KEGG_2021_Human	B cell receptor signaling pathway	2/81	0.004241897027183041	0.008771380293497137	25.281645569620252	-32.95657984925952	AKT1;PIK3CA
KEGG_2021_Human	Fc gamma R-mediated phagocytosis	2/97	0.006031622120792857	0.012063244241585714	20.981578947368423	-27.909669646620806	AKT1;PIK3CA
KEGG_2021_Human	Phosphatidylinositol signaling system	2/97	0.006031622120792857	0.012063244241585714	20.981578947368423	-27.909669646620806	PIK3CA;PTEN
KEGG_2021_Human	Progesterone-mediated oocyte maturation	2/100	0.006399778215208473	0.012393221305641803	20.331632653061224	-27.120602948412195	AKT1;PIK3CA
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.012393221305641803	20.331632653061224	-27.120602948412195	AKT1;PIK3CA
KEGG_2021_Human	C-type lectin receptor signaling pathway	2/104	0.006906399428166279	0.012575831794571432	19.524509803921568	-26.130280011490946	AKT1;PIK3CA
KEGG_2021_Human	Chagas disease	2/102	0.006650847322673755	0.012575831794571432	19.92	-26.61700675496218	AKT1;PIK3CA
KEGG_2021_Human	Toll-like receptor signaling pathway	2/104	0.006906399428166279	0.012575831794571432	19.524509803921568	-26.130280011490946	AKT1;PIK3CA
KEGG_2021_Human	T cell receptor signaling pathway	2/104	0.006906399428166279	0.012575831794571432	19.524509803921568	-26.130280011490946	AKT1;PIK3CA
KEGG_2021_Human	TNF signaling pathway	2/112	0.007973056255711614	0.014304600929364955	18.086363636363636	-24.33571316400054	AKT1;PIK3CA
KEGG_2021_Human	Cholinergic synapse	2/113	0.008111349626545349	0.014341806586065691	17.92117117117117	-24.127023560492017	AKT1;PIK3CA
KEGG_2021_Human	Alzheimer disease	3/369	0.008924054845697141	0.015402954561011727	9.018735362997658	-18.187178129854335	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Neurotrophin signaling pathway	2/119	0.008964014539605185	0.015402954561011727	16.98931623931624	-22.939511285821055	AKT1;PIK3CA
KEGG_2021_Human	Platelet activation	2/124	0.009704304916610982	0.016443405553146388	16.2827868852459	-22.027132854342252	AKT1;PIK3CA
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.01698193927123251	15.886	-21.510038502238015	AKT1;PIK3CA
KEGG_2021_Human	Relaxin signaling pathway	2/129	0.010471317399144716	0.01726352327967102	15.631889763779528	-21.1770620526928	AKT1;PIK3CA
KEGG_2021_Human	Yersinia infection	2/137	0.011753397776716717	0.018622266607265448	14.690740740740742	-19.931093924152265	AKT1;PIK3CA
KEGG_2021_Human	Estrogen signaling pathway	2/137	0.011753397776716717	0.018622266607265448	14.690740740740742	-19.931093924152265	AKT1;PIK3CA
KEGG_2021_Human	Apelin signaling pathway	2/137	0.011753397776716717	0.018622266607265448	14.690740740740742	-19.931093924152265	AKT1;MTOR
KEGG_2021_Human	Measles	2/139	0.012084353093672291	0.018661912372506573	14.472627737226277	-19.639406588988233	AKT1;PIK3CA
KEGG_2021_Human	Fluid shear stress and atherosclerosis	2/139	0.012084353093672291	0.018661912372506573	14.472627737226277	-19.639406588988233	AKT1;PIK3CA
KEGG_2021_Human	Ubiquitin mediated proteolysis	2/140	0.012251383469910176	0.01868335979161302	14.365942028985508	-19.496322510730057	VHL;WWP1
KEGG_2021_Human	Apoptosis	2/142	0.012588538285001706	0.01896051445395319	14.157142857142857	-19.21549786230027	AKT1;PIK3CA
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	2/143	0.01275865818396982	0.018982393883467293	14.054964539007091	-19.077689748676264	AKT1;PIK3CA
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.021870963597156304	12.933006535947712	-17.54750234216727	AKT1;PIK3CA
KEGG_2021_Human	Hepatitis C	2/157	0.015246968798416489	0.022144407064366805	12.762903225806452	-17.312716751580805	AKT1;PIK3CA
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.02322762359097452	12.35625	-16.748364182562245	AKT1;PIK3CA
KEGG_2021_Human	Influenza A	2/172	0.01812904275363809	0.025717944371440083	11.614705882352942	-15.707848772731996	AKT1;PIK3CA
KEGG_2021_Human	Herpes simplex virus 1 infection	3/498	0.020174850542549024	0.028291169726333113	6.556709956709956	-12.239051897711217	AKT1;MTOR;PIK3CA
KEGG_2021_Human	Chemokine signaling pathway	2/192	0.0223068963273402	0.030925469908358004	10.365789473684211	-13.920708621090329	AKT1;PIK3CA
KEGG_2021_Human	Viral carcinogenesis	2/203	0.024762333575826773	0.03356671884723184	9.784825870646767	-13.073912909097736	CDKN2A;PIK3CA
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.03356671884723184	9.835	-13.147442958027579	AKT1;PIK3CA
KEGG_2021_Human	Rap1 signaling pathway	2/210	0.026381440852868025	0.03536852509944944	9.447115384615385	-12.577019344618241	AKT1;PIK3CA
KEGG_2021_Human	cAMP signaling pathway	2/216	0.027803609837697526	0.03647355269031288	9.175233644859814	-12.174459052502558	AKT1;PIK3CA
KEGG_2021_Human	Lipid and atherosclerosis	2/215	0.027564399546120597	0.03647355269031288	9.219483568075118	-12.240131856521	AKT1;PIK3CA
KEGG_2021_Human	Salmonella infection	2/249	0.03617242514905692	0.046947190087073876	7.915991902834008	-10.280113155611538	AKT1;PIK3CA
KEGG_2021_Human	Aldosterone-regulated sodium reabsorption	1/37	0.04489527895199197	0.05705441700148979	24.790123456790123	-13.876145105511855	PIK3CA
KEGG_2021_Human	Thyroid cancer	1/37	0.04489527895199197	0.05705441700148979	24.790123456790123	-13.876145105511855	RET
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.06160244030893604	6.657534246575342	-8.337786615237395	AKT1;NF1
KEGG_2021_Human	Bladder cancer	1/41	0.04963848036556211	0.061794842904067115	22.3	-12.692261742471414	CDKN2A
KEGG_2021_Human	Bacterial invasion of epithelial cells	1/77	0.09138288226635771	0.11261324885349132	11.68421052631579	-7.04872976578505	PIK3CA
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.14025669103154043	9.130584192439862	-5.49346810373269	PIK3CA
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.14421761099983627	8.764576457645765	-5.262086311101535	PIK3CA
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.14794119641216757	8.345911949685535	-4.994589105830365	MTOR
KEGG_2021_Human	Glucagon signaling pathway	1/107	0.1249011740201087	0.14794119641216757	8.345911949685535	-4.994589105830365	AKT1
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.15294348803448388	7.964964964964965	-4.748494648054986	AKT1
KEGG_2021_Human	Leukocyte transendothelial migration	1/114	0.13256015588280526	0.15402227635906898	7.822025565388397	-4.655477238055189	PIK3CA
KEGG_2021_Human	Cell cycle	1/124	0.14339691916847833	0.16504173715617318	7.177055103884372	-4.231046804704064	CDKN2A
KEGG_2021_Human	Dopaminergic synapse	1/132	0.1519784338028618	0.17167934188841796	6.73197625106022	-3.9335418472006	AKT1
KEGG_2021_Human	Natural killer cell mediated cytotoxicity	1/131	0.1509099928727911	0.17167934188841796	6.7846153846153845	-3.968927686510734	PIK3CA
KEGG_2021_Human	Adrenergic signaling in cardiomyocytes	1/150	0.1710046090025842	0.19139965411298415	5.905294556301268	-3.370661515310376	AKT1
KEGG_2021_Human	Cushing syndrome	1/155	0.17622102470306392	0.1954451364888527	5.70995670995671	-3.235678410841787	CDKN2A
KEGG_2021_Human	cGMP-PKG signaling pathway	1/167	0.1886201000678787	0.20731218205658739	5.289156626506024	-2.942334294710352	AKT1
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.2198861218819619	4.896958410924891	-2.6658400097237527	AKT1
KEGG_2021_Human	Axon guidance	1/182	0.2038826300760579	0.2201210696396377	4.841620626151013	-2.6265948500338347	PIK3CA
KEGG_2021_Human	Regulation of actin cytoskeleton	1/218	0.2394639268571876	0.2562684129524288	4.019969278033794	-2.037730229066884	PIK3CA
KEGG_2021_Human	Thermogenesis	1/232	0.25290994493508406	0.2659914938110367	3.7696007696007694	-1.8563524399324505	MTOR
KEGG_2021_Human	Coronavirus disease	1/232	0.25290994493508406	0.2659914938110367	3.7696007696007694	-1.8563524399324505	PIK3CA
KEGG_2021_Human	Calcium signaling pathway	1/240	0.2604969587424048	0.2716293074066102	3.6397024639702464	-1.7619943041292825	RET
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.2809592829539314	3.4603806994245243	-1.6315316807371463	WWP1
KEGG_2021_Human	Prion disease	1/273	0.2910658516731848	0.29840364625318105	3.184640522875817	-1.4307154955453085	PIK3CA
KEGG_2021_Human	Huntington disease	1/306	0.32049274018188956	0.32583428585158775	2.8280510018214935	-1.1715156192121785	MTOR
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3726144421832127	2.3584328129782675	-0.8341701676241932	MTOR
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	MTOR
